Presentation ESC 2025 Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT Presenter: Borja Ibanez August 30, 2025 REGISTER for free or LOG IN to view this content Coronary Heart Failure Presentation ESC 2025 Up Next Presentation ESC 2025 AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation Presenter: Rohan Wijesurendra August 29, 2025 More slides + Presentation ESC 2025 Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk Presenter: Brian Bergmark August 30, 2025 Presentation ESC 2025 Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial Presenter: David Newby September 03, 2025 We Recommend
Presentation ESC 2025 AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation Presenter: Rohan Wijesurendra August 29, 2025
Presentation ESC 2025 Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk Presenter: Brian Bergmark August 30, 2025
Presentation ESC 2025 Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial Presenter: David Newby September 03, 2025